Viewing Study NCT01493960


Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2026-05-19 @ 1:23 PM
Study NCT ID: NCT01493960
Status: COMPLETED
Last Update Posted: 2023-01-10
First Post: 2011-12-12
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: The Efficacy and Safety of Cobitolimod (Kappaproct®) in Chronic Active Treatment Refractory Ulcerative Colitis Patients
Sponsor: InDex Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colitis, Ulcerative View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Colitis, Ulcerative View
None Gastrointestinal Diseases View
None Inflammatory Bowel Diseases View
None Immunomodulatory Therapy View
None Glucocorticoids View
None Anti-Inflammatory Agents View
None Therapeutic uses View